MunirShahjahanMD

Pathology • Houston, TX

Hematopathology, Anatomic Pathology, Clinical Pathology

Physician

Join to view full profile

Dr. Shahjahan is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Shahjahan's full profile

Already have an account?

Office
6565 Fannin St
# M227
Houston, TX 77030
Phone+1 713-441-3490

Fax+1 713-793-1603

Education & Training

Methodist Hospital (Houston)Fellowship, Hematopathology, 2009 - 2010
Methodist Hospital (Houston)Residency, Pathology-Anatomic and Clinical, 2005 - 2009
Dhaka Medical CollegeClass of 1990

Certifications & Licensure

NY State Medical License 2021 - 2026
TX State Medical License 2010 - 2025
AR State Medical License 2013 - 2020
LA State Medical License 2013 - 2020
NM State Medical License 2013 - 2020
TN State Medical License 2013 - 2020
AL State Medical License 2013 - 2019
MO State Medical License 2016 - 2019
OK State Medical License 2013 - 2019
SC State Medical License 2014 - 2019
GA State Medical License 2014 - 2018
NC State Medical License 2013 - 2018
American Board of Pathology Pathology - Anatomic/Pathology - Clinical
American Board of Pathology Hematopathology
Join now to see all

Publications & Presentations

PubMed

312 citations
Nonablative versus reduced-intensity conditioning regimens in the treatment of acute myeloid leukemia and high-risk myelodysplastic syndrome: dose is relevant for long...
Marcos de Lima, Athanasios Anagnostopoulos, Mark F. Munsell, Munir Shahjahan, Naoto T. Ueno
Blood. 2004-08-01
60 citations
Disease burden may identify patients more likely to benefit from second allogeneic hematopoietic stem cell transplantation to treat relapsed acute myelogenous leukemia
Chitra Hosing, Rima M. Saliba, Munir Shahjahan, Eli Estey, Daniel R. Couriel
Bone Marrow Transplantation. 2005-07-01
338 citations
Once-daily intravenous busulfan and fludarabine: clinical and pharmacokinetic results of a myeloablative, reduced-toxicity conditioning regimen for allogeneic stem cel...
Marcos de Lima, Daniel R. Couriel, Peter F. Thall, Xuemei Wang, Timothy Madden
Blood. 2004-08-01